Brief: Heron Therapeutics Announces CMS Approves Transitional Pass-Through Status For APONVIE

Heron Therapeutics

13/03/2023 13:34

March 13 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES CENTERS FOR MEDICARE &
MEDICAID
SERVICES (CMS) GRANTED PASS-THROUGH PAYMENT STATUS FOR APONVIE™,
EFFECTIVE APRIL 1, 2023
    * HERON THERAPEUTICS - CMS APPROVED TRANSITIONAL
PASS-THROUGH
STATUS FOR APONVIE INJECTABLE EMULSION, FOR 3 YEARS FROM APRIL
1, 2023 UNDER C-CODE C9145

Source text for Eikon:  ID:nPn4Hq6lYa 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))